Total thrombin‐activatable fibrinolysis inhibitor (TAFI) antigen and pro‐TAFI in patients with haemophilia A
- 12 November 2001
- journal article
- research article
- Published by Wiley in Haemophilia
- Vol. 7 (6) , 557-560
- https://doi.org/10.1046/j.1365-2516.2001.00571.x
Abstract
Pro‐thrombin‐activatable fibrinolysis inhibitor (pro‐TAFI), also known as TAFI, procarboxypeptidase U, or procarboxypeptidase B, is a relatively recently described plasma glycoprotein synthesized in ...Keywords
This publication has 16 references indexed in Scilit:
- Low Levels of Thrombin Activatable Fibrinolysis Inhibitor (TAFI) in Patients with Chronic Liver DiseaseThrombosis and Haemostasis, 2001
- Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosisBlood, 2000
- Inactivation of Active Thrombin-activable Fibrinolysis Inhibitor Takes Place by a Process That Involves Conformational Instability Rather Than Proteolytic CleavageJournal of Biological Chemistry, 2000
- Reduced activity of TAFI (thrombin‐activatable fibrinolysis inhibitor) in acute promyelocytic leukaemiaBritish Journal of Haematology, 2000
- CPR-Total (TAFI and Activated TAFI) Levels in Plasma/Serum of HemophiliacsMicrobiology and Immunology, 2000
- Plasma TAFI Antigen Variations in Healthy SubjectsThrombosis and Haemostasis, 2000
- A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1998
- TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin ComplexPublished by Elsevier ,1996
- Plasma carboxypeptidases as regulators of the plasminogen system.Journal of Clinical Investigation, 1995
- Purification and Characterization of TAFI, a Thrombin-activable Fibrinolysis InhibitorJournal of Biological Chemistry, 1995